Overview

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Status:
Unknown status

Trial end date:
2019-11-01

Target enrollment:

Participant gender:

Summary

This study evaluates the diagnostic accuracy of an USPIO contrast agent (ferumoxtran-10) in combination with 7 Tesla MRI to detect lymph node metastases in rectal and breast cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Radboud University